摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(苯甲氧基)羰基]-O-(苯基甲基)-D-酪氨酸 | 92455-53-3

中文名称
N-[(苯甲氧基)羰基]-O-(苯基甲基)-D-酪氨酸
中文别名
——
英文名称
Cbz-D-Tyr(OBz)-H
英文别名
(N-benzyloxycarbonyl-O-benzyl)-D-tyrosine;Z-D-Tyr(Bzl)-OH;(2R)-2-(phenylmethoxycarbonylamino)-3-(4-phenylmethoxyphenyl)propanoic acid
N-[(苯甲氧基)羰基]-O-(苯基甲基)-D-酪氨酸化学式
CAS
92455-53-3
化学式
C24H23NO5
mdl
——
分子量
405.45
InChiKey
IPAODWFPTVIUSZ-JOCHJYFZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    113-119℃
  • 沸点:
    624.4±55.0 °C(Predicted)
  • 密度:
    1.249±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    30
  • 可旋转键数:
    10
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    84.9
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:f3f672f405902bcbda4457bee44588fb
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Z-D-Tyr(bzl)-oh
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Z-D-Tyr(bzl)-oh
CAS number: 92455-53-3

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C24H23NO5
Molecular weight: 405.4

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    N-[(苯甲氧基)羰基]-O-(苯基甲基)-D-酪氨酸吡啶三聚氟氰 作用下, 以 二氯甲烷 为溶剂, 反应 1.25h, 以72%的产率得到N-(Carbobenzyloxy)-O-benzyl-D-tyrosinecarboxylic acid fluoride
    参考文献:
    名称:
    A Mimic of Both a Torsionally-Distorted Peptide Ground State and the Transition State for Peptide Bond Hydrolysis: Synthesis of a Spiro[4.4]nonyl Derivative
    摘要:
    DOI:
    10.1021/jo00121a072
点击查看最新优质反应信息

文献信息

  • An Efficient Approach to Chiral C8/C9-Piperazino-Substituted 1,4-Benzodiazepin-2-ones as Peptidomimetic Scaffolds
    作者:Stefania Butini、Emanuele Gabellieri、Paul Brady Huleatt、Giuseppe Campiani、Silvia Franceschini、Margherita Brindisi、Sindu Ros、Salvatore Sanna Coccone、Isabella Fiorini、Ettore Novellino、Gianluca Giorgi、Sandra Gemma
    DOI:10.1021/jo8015456
    日期:2008.11.7
    a versatile approach to introduce cyclic, protonatable functionality at C8/C9. Introduction of the piperazine system at C8 and C9 gave access to a unique functionalization of the versatile benzodiazepine skeleton, broadening tailoring options on the benzofused side of the molecule, and the possibility of discovering novel peptidomimetics potentially able to modulate protein-protein interactions. Coupling
    干扰生物过程的一种有前途的方法是通过充当拟肽的小分子调节蛋白质-蛋白质相互作用。1,4-苯并二氮杂pine骨架已被广泛报道为模仿肽的致药系统。尽管已经公开了几种通往C6-8取代的苯并二氮杂卓的合成途径,但几乎没有报道在C9处被取代的1,4-苯并二氮杂卓。在这里,我们描述了一种通用的方法,可以在C8 / C9处引入循环的,可质子化的功能。在C8和C9引入哌嗪系统后,即可获得通用的苯并二氮杂skeleton骨架的独特功能化,拓宽了分子在苯并稠合侧的剪裁选择,并发现了可能调节蛋白质-蛋白质相互作用的新型肽模拟物。在温和条件下,将活化的氨基酸与反应性较弱的苯胺偶联,同时避免了外消旋作用,可轻松获得这些化合物。通过使用三苯基膦和六氯丙酮,在低温和无酸/碱的条件下利用酰氯的快速形成,可以实现有效的氨基酸活化。该方法成功地导致了高反应产率,没有产生外消旋作用(ee> 98%,如通过使用手性溶剂化剂所证明
  • Nouveaux composés amidiques des 1-(alcoxybenzyl) pipérazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent
    申请人:ADIR ET COMPAGNIE
    公开号:EP0533516A2
    公开(公告)日:1993-03-24
    Composés de formule (I) : avec R1, R2, et n tels que définis dans la description. Médicaments.
    式 (I) : 其中 R1、R2 和 n 如说明中所定义。药物。
  • Spiroleucettadine: synthetic studies and investigations towards structural revision
    作者:Nicholas Aberle、Simon P.B. Ovenden、Guillaume Lessene、Keith G. Watson、Brian J. Smith
    DOI:10.1016/j.tetlet.2007.01.088
    日期:2007.3
    Synthetic efforts towards spiroleucettadine are described, including the enantioselective synthesis of the presumed biosynthetic precursor. High level density functional theory calculations were used to predict the C-13 NMR shifts of possible alternative structures and, along with a re-evaluation of the available NMR data, allow the proposal of revised structures for this spirocyclic alkaloid. (c) 2007 Elsevier Ltd. All rights reserved.
  • The synthesis of cyclobutanol-containing dipeptide analogues
    作者:Ping Yuan、Mark R. Driscoll、Susan J. Raymond、David E. Hansen、Richard A. Blatchly
    DOI:10.1016/s0040-4039(00)73389-2
    日期:1994.8
    The dipeptide analogue methyl trans-2-[(t-butoxycarbonyl)amino]-trans-3-hydroxycyclobutanecarboxylate (5a) and its cis,cis-isomer (5b) have been synthesized, and each has been incorporated into a longer peptide sequence.
  • US5340809A
    申请人:——
    公开号:US5340809A
    公开(公告)日:1994-08-23
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物